サンプル依頼リスト カート
  • English
  • Korean
表紙：小児膀胱治療の世界市場レポート 2024年
市場調査レポート
商品コード
1415690

小児膀胱治療の世界市場レポート 2024年

Pediatric Bladder Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
小児膀胱治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

小児膀胱治療市場規模は近年力強く成長しています。2023年の33億6,000万米ドルから2024年には35億4,000万米ドルに、CAGR5.3％で拡大します。実績期間の成長は、小児膀胱疾患の有病率、小児膀胱疾患に対する認識の高まり、小児のヘルスケアへのアクセスの増加、可処分所得の上昇に起因しています。

小児膀胱治療の市場規模は、今後数年間で安定した成長が見込まれます。2028年には年間平均成長率（CAGR）4.5％で42億3,000万米ドルに成長します。予測期間の成長は、人口の高齢化、小児の慢性疾患の有病率の上昇、ヘルスケアへのアクセスの増加、治療における個別化医療の需要に起因しています。予測期間における主な動向としては、新しく革新的な小児膀胱治療の採用、デジタルヘルス技術、早期介入と予防、非侵襲的治療などが挙げられます。

小児膀胱疾患の有病率の増加は、予測可能な将来における小児膀胱治療市場の拡大に拍車をかけると考えられます。小児膀胱障害には、小児の膀胱の正常な機能を障害するさまざまな病状が含まれます。これらの疾患は、二分脊椎や神経障害などの疾患と関連していることが多く、小児の泌尿器合併症を引き起こすため、効果的な治療アプローチが必要となります。例えば、2023年3月に実施され、Multidisciplinary Digital Publishing Institute（MDPI）により発表された神経因性膀胱（NGB、小児膀胱障害の一種）の小児患者1,065人を対象とした研究では、これらの患者の38.9％が二分脊椎であることが明らかになった。下部尿路感染症は一般的な合併症（18.1％）であり、特に開放性二分脊椎患者（54.1％）に多かった。12ヵ月間の追跡調査において、一般的な合併症は下部尿路感染症の再発（18.1％）、尿失禁（8.0％）、水腎症（5.6％）であり、7.9％の患者が4回以上の下部尿路感染症を繰り返していました。その結果、小児膀胱疾患の急増が小児膀胱治療市場の成長促進要因となっています。

低侵襲手術の受け入れ拡大が、今後数年間の小児膀胱治療市場の成長に革命をもたらすと考えられています。低侵襲手術は、小さな切開創、繊細な器具、高度な画像技術を使用することを特徴とする医療・手術法を包含します。小児膀胱治療における低侵襲手術の適用拡大には、回復の早さ、不快感の軽減、安全性の向上など、いくつかの利点があります。これらの利点から、低侵襲手技は小児の膀胱の問題に対処するための、より効果的で適切な選択肢と位置づけられています。例えば、米国のロボットシステムメーカーであるIntuitive Surgical Inc.の報告によると、2022年にはVinci Surgical Systemsを使用した手術が約187万5,000件行われ、2021年にVinci Surgical Systemsを使用した手術が約159万4,000件であったことと比較すると、18％の急増となった。このように、低侵襲手術の普及が小児膀胱治療市場の成長を牽引しています。

2023年の小児膀胱治療市場では北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域と予想されます。小児膀胱治療レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東およびアフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の小児膀胱治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 日中失禁
  • 夜尿症
  • その他
  • 世界の小児膀胱治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 泌尿器療法
  • 薬剤
  • 外科的再建
  • その他
  • 世界の小児膀胱治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界の小児膀胱治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • オンライン薬局
  • 小売薬局
  • 世界の小児膀胱治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 在宅ケア
  • 専門クリニック
  • その他

第7章 地域および国の分析

  • 世界の小児膀胱治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の小児膀胱治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 小児膀胱治療市場の競合情勢
  • 小児膀胱治療市場の企業プロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd
    • AbbVie Inc.
    • Novartis AG
    • Sanofi SA

第31章 その他の主要および革新的な企業

  • AstraZeneca Plc
  • Takeda Pharmaceutical Company Limited
  • Medtronic Plc
  • Teva Pharmaceutical Industries Ltd.
  • Boston Scientific Corporation
  • Mylan N.V.
  • Astellas Pharma Inc
  • Bausch Health Companies Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Cook Medical Inc.
  • Ipsen Pharma
  • Aurobindo Pharma Ltd
  • Endo International plc
  • Coloplast AIS
  • Endo International plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12289

“Pediatric Bladder Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric bladder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric bladder treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pediatric bladder treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Diurnal Incontinence; Enuresis; Other Types
  • 2) By Treatment: Urotherapy; Medication; Surgical Reconstruction; Other Treatments
  • 3) By Route of Administration: Oral; Parenteral; Other Route of Administrations
  • 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
  • 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; AbbVie Inc.; Novartis AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Pediatric bladder disorders encompass a range of medical conditions that affect the urinary bladder in children, including issues related to bladder function, control, and structure. The treatment of pediatric bladder disorders involves the management and addressing of bladder dysfunction, with the choice of treatment methods contingent on factors like the child's age, overall health, medical history, specific bladder symptoms, and the underlying cause of nerve damage or neurological conditions.

The primary categories of pediatric bladder treatment for these disorders consist of diurnal incontinence, enuresis, and other related conditions. Diurnal incontinence pertains to the involuntary release of urine during daylight hours, when an individual should typically have control over their bladder. Treatment for diurnal incontinence in children often includes behavioral and lifestyle adjustments, such as educating the child to recognize and respond to the sensation of a full bladder, encouraging regular bathroom breaks, and addressing any issues related to constipation. These conditions are also managed through urotherapy, medication, surgical reconstruction, and other treatment methods, administered orally, parenterally, or through alternative routes. The treatment products are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and cater to end users such as hospitals, homecare services, specialty clinics, and more.

The pediatric bladder treatment market research report is one of a series of new reports from The Business Research Company that provides pediatric bladder treatment market statistics, including pediatric bladder treatment industry global market size, regional shares, competitors with a pediatric bladder treatment market share, detailed pediatric bladder treatment market segments, market trends and opportunities and any further data you may need to thrive in the pediatric bladder treatment industry. This pediatric bladder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric bladder treatment market size has grown strongly in recent years. It will grow from $3.36 billion in 2023 to $3.54 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to prevalence of pediatric bladder conditions, growing awareness of pediatric bladder conditions, increasing access to healthcare for children, rising disposable incomes.

The pediatric bladder treatment market size is expected to see steady growth in the next few years. It will grow to $4.23 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to aging population, rising prevalence of chronic diseases in children, increasing access to healthcare, demand for personalized medicine in the treatment. Major trends in the forecast period include adoption of new and innovative pediatric bladder treatments, digital health technologies, early intervention and prevention, non-invasive treatments.

The rising prevalence of pediatric bladder disorders is poised to fuel the expansion of the pediatric bladder treatment market in the foreseeable future. Pediatric bladder disorders encompass a range of medical conditions that disrupt the normal functionality of the urinary bladder in children. These conditions, often associated with ailments like spina bifida and neurological disorders, result in urinary complications in children, necessitating effective treatment approaches. For example, a study involving 1,065 pediatric patients with neurogenic bladder (NGB, a type of pediatric bladder disorder), conducted in March 2023 and published by the Multidisciplinary Digital Publishing Institute (MDPI), revealed that 38.9% of these patients had spina bifida. Lower urinary tract infections were a prevalent complication (18.1%), especially among patients with open spina bifida (54.1%). Over a 12-month follow-up, common complications included recurrent lower urinary tract infections (18.1%), urinary incontinence (8.0%), and hydronephrosis (5.6%), with 7.9% of patients experiencing four or more recurring lower urinary tract infections. Consequently, the surge in pediatric bladder disorders is a key driver of growth in the pediatric bladder treatment market.

The growing acceptance of minimally invasive procedures is poised to revolutionize the pediatric bladder treatment market's growth in the coming years. Minimally invasive procedures encompass medical and surgical methods characterized by the use of small incisions, delicate instruments, and advanced imaging technology. The rising application of minimally invasive interventions in pediatric bladder treatment offers several advantages, including swifter recovery, reduced discomfort, and enhanced safety. These benefits position minimally invasive techniques as more effective and appropriate options for addressing pediatric bladder issues. For example, as reported by Intuitive Surgical Inc., a US-based manufacturer of robotic systems, the year 2022 witnessed around 1,875,000 surgical procedures carried out using Vinci Surgical Systems, signifying an impressive 18% surge in comparison to the approximately 1,594,000 surgical procedures conducted with Vinci Surgical Systems in 2021. As such, the increasing adoption of minimally invasive procedures drives the growth of the pediatric bladder treatment market.

The absence of physical restraint-free treatment poses a significant challenge and has the potential to restrict the market's growth during the forecast period. The utilization of physical restraints during treatment stands as a substantial hindrance in the pediatric bladder treatment market, primarily due to the physical and emotional distress it can inflict upon patients and their caregivers. It is associated with negative perceptions of healthcare providers, the treatment process, concerns about the lack of consent, and safety issues. For example, as per a qualitative study published in the Journal of Child Health Care in 2021, the absence of physical restraint is sometimes regarded as a limitation in providing care or treatment for pediatric patients. This can create a notable barrier to effective treatment, causing physical and emotional distress for the patient and their caregivers. Consequently, the lack of physical restraint-free treatment hampers the growth of the pediatric bladder treatment market.

The prominent companies operating in the pediatric bladder treatment market are actively engaged in the development of precision therapies aimed at addressing specific medical conditions within the pediatric population. These therapies offer tailored solutions to accommodate the unique challenges and medical requirements of pediatric patients with bladder disorders. Targeted pediatric bladder treatment therapies are characterized by their specialized and precise approach to effectively cater to the needs of children. For example, in March 2021, Astellas Pharma Inc., a Japan-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron extended-release oral suspension). These therapies are designed to treat neurogenic detrusor overactivity (NDO) in pediatric patients aged three years and older. NDO is a bladder dysfunction resulting from nerve damage, leading to involuntary bladder contractions and causing symptoms like frequent urination, urgency to urinate, and urinary incontinence. Myrbetriq tablets (Mirabegron extended-release tablets) are currently available in the U.S. market.

In July 2021, UroMedical Corporation, a medical device manufacturer based in the United States, completed the acquisition of Micron Medical Corporation, and the terms of the deal were not disclosed. This strategic acquisition allowed UroMedical Corporation to bolster its assets in the field of urology, thereby establishing itself as a prominent provider of urology-focused products. The move involved ongoing essential clinical trials, bolstered its market presence, and streamlined the regulatory approval process for innovative neurostimulation solutions aimed at enhancing the management of urological conditions, with a particular emphasis on pediatric neurogenic bladder. Micron Medical Corporation, also based in the United States, is a biopharmaceutical company renowned for its expertise in pediatric neurogenic bladder management.

Major players in the pediatric bladder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca Plc, Takeda Pharmaceutical Company Limited, Medtronic Plc, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Mylan N.V., Astellas Pharma Inc, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cook Medical Inc., Ipsen Pharma, Aurobindo Pharma Ltd, Endo International plc, Coloplast AIS, Endo International plc, Apotex Inc., Amneal Pharmaceuticals LLC., Orion Corporation, Taro Pharmaceuticals, Laborie Medical Technologies Corp., Salix Pharmaceuticals, TherapeuticsMD Inc., UroGen Pharma, Palette Life Sciences, Sumitovant Biopharma.

North America was the largest region in the pediatric bladder treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pediatric bladder treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pediatric bladder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pediatric bladder treatment market consists of revenues earned by entities by providing medical consultations, nutritional counseling, catheterization and therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric bladder treatment market also includes sales of ultrasound devices, cystoscopes, antibiotics, urinary catheters, incontinence products and surgical instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Pediatric Bladder Treatment Market Characteristics

3. Pediatric Bladder Treatment Market Trends And Strategies

4. Pediatric Bladder Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pediatric Bladder Treatment Market Size and Growth

  • 5.1. Global Pediatric Bladder Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pediatric Bladder Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pediatric Bladder Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pediatric Bladder Treatment Market Segmentation

  • 6.1. Global Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diurnal Incontinence
  • Enuresis
  • Other Types
  • 6.2. Global Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Urotherapy
  • Medication
  • Surgical Reconstruction
  • Other Treatments
  • 6.3. Global Pediatric Bladder Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Route of Administrations
  • 6.4. Global Pediatric Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • 6.5. Global Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users

7. Pediatric Bladder Treatment Market Regional And Country Analysis

  • 7.1. Global Pediatric Bladder Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pediatric Bladder Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pediatric Bladder Treatment Market

  • 8.1. Asia-Pacific Pediatric Bladder Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pediatric Bladder Treatment Market

  • 9.1. China Pediatric Bladder Treatment Market Overview
  • 9.2. China Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pediatric Bladder Treatment Market

  • 10.1. India Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pediatric Bladder Treatment Market

  • 11.1. Japan Pediatric Bladder Treatment Market Overview
  • 11.2. Japan Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pediatric Bladder Treatment Market

  • 12.1. Australia Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pediatric Bladder Treatment Market

  • 13.1. Indonesia Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pediatric Bladder Treatment Market

  • 14.1. South Korea Pediatric Bladder Treatment Market Overview
  • 14.2. South Korea Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pediatric Bladder Treatment Market

  • 15.1. Western Europe Pediatric Bladder Treatment Market Overview
  • 15.2. Western Europe Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pediatric Bladder Treatment Market

  • 16.1. UK Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pediatric Bladder Treatment Market

  • 17.1. Germany Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pediatric Bladder Treatment Market

  • 18.1. France Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pediatric Bladder Treatment Market

  • 19.1. Italy Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pediatric Bladder Treatment Market

  • 20.1. Spain Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pediatric Bladder Treatment Market

  • 21.1. Eastern Europe Pediatric Bladder Treatment Market Overview
  • 21.2. Eastern Europe Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pediatric Bladder Treatment Market

  • 22.1. Russia Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pediatric Bladder Treatment Market

  • 23.1. North America Pediatric Bladder Treatment Market Overview
  • 23.2. North America Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pediatric Bladder Treatment Market

  • 24.1. USA Pediatric Bladder Treatment Market Overview
  • 24.2. USA Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pediatric Bladder Treatment Market

  • 25.1. Canada Pediatric Bladder Treatment Market Overview
  • 25.2. Canada Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pediatric Bladder Treatment Market

  • 26.1. South America Pediatric Bladder Treatment Market Overview
  • 26.2. South America Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pediatric Bladder Treatment Market

  • 27.1. Brazil Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pediatric Bladder Treatment Market

  • 28.1. Middle East Pediatric Bladder Treatment Market Overview
  • 28.2. Middle East Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pediatric Bladder Treatment Market

  • 29.1. Africa Pediatric Bladder Treatment Market Overview
  • 29.2. Africa Pediatric Bladder Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pediatric Bladder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pediatric Bladder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pediatric Bladder Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Pediatric Bladder Treatment Market Competitive Landscape
  • 30.2. Pediatric Bladder Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sanofi S.A.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pediatric Bladder Treatment Market Other Major And Innovative Companies

  • 31.1. AstraZeneca Plc
  • 31.2. Takeda Pharmaceutical Company Limited
  • 31.3. Medtronic Plc
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Boston Scientific Corporation
  • 31.6. Mylan N.V.
  • 31.7. Astellas Pharma Inc
  • 31.8. Bausch Health Companies Inc.
  • 31.9. Sun Pharmaceutical Industries Ltd.
  • 31.10. Cook Medical Inc.
  • 31.11. Ipsen Pharma
  • 31.12. Aurobindo Pharma Ltd
  • 31.13. Endo International plc
  • 31.14. Coloplast AIS
  • 31.15. Endo International plc

32. Global Pediatric Bladder Treatment Market Competitive Benchmarking

33. Global Pediatric Bladder Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pediatric Bladder Treatment Market

35. Pediatric Bladder Treatment Market Future Outlook and Potential Analysis

  • 35.1 Pediatric Bladder Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pediatric Bladder Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pediatric Bladder Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer